Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies
- PMID: 30584387
- PMCID: PMC6287516
- DOI: 10.2147/DNND.S138835
Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies
Abstract
Bowel dysfunction in patients with multiple sclerosis (MS) is highly prevalent. Constipation and fecal incontinence can coexist and alternate, impacting on the patient's quality of life and social interactions, as well as burdening the caregivers. The cost for the health care providers is also significant, with increased number of hospital admissions, treatment-related costs, and hospital appointments. The origin is multifactorial, and includes alteration of neurological pathways, polypharmacy, behavioral elements, and ability to access the toilet. Every patient with MS should be sensitively questioned about bowel function, and red flag symptoms should prompt adequate investigations. Manipulation of life style factors and establishment of a bowel regime should be attempted in the first place, and if this fails, other measures such as biofeedback and transanal irrigation should be included. A stoma can improve quality of life, and is not necessarily a last-ditch option. Antegrade colonic enemas can also be an effective option, whilst neuromodulation has not proved its role yet. Effective treatment of bowel dysfunction improves quality of life, reduces incidence of urinary tract infection, and reduces health care costs.
Keywords: constipation; fecal incontinence; multiple sclerosis; neurogenic bowel dysfunction.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
Figures




References
-
- Compston A. Making progress on the natural history of multiple sclerosis. Brain. 2006;129(Pt 3):561–563. - PubMed
-
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983;33(11):1444–1452. - PubMed
-
- Losseff NA, Webb SL, O’Riordan JI, et al. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain. 1996;119(Pt 3):701–708. - PubMed
Publication types
LinkOut - more resources
Full Text Sources